Eczema in Adults vs Children: Key Differences Explained

Written by Aisha Saleem, Pharmacist & Health Writer at PharmaHealths.com

Last Updated: August 2026

Eczema is one of the most common inflammatory skin conditions worldwide, affecting people at every stage of life. But the way it looks, where it appears, what triggers it, and how likely it is to resolve differ significantly between children and adults. Understanding these differences is not just clinically useful, it directly affects treatment decisions, management expectations, and the kind of support that is most helpful at each life stage.

This article covers the key distinctions in how eczema presents across age groups, what drives those differences at a biological level, and what they mean practically for management.

How Common Is Eczema Across Age Groups?

Eczema affects approximately 20% of children and 3 to 10% of adults globally, according to a review published in the Lancet. It is one of the most prevalent chronic skin conditions in childhood and remains a significant burden in adult life. The condition typically appears before the age of five in around 85% of affected individuals, according to research published in the Journal of Allergy and Clinical Immunology. However, adult-onset eczema, where symptoms begin after the age of 18 without a clear childhood history, is increasingly recognized and accounts for a meaningful proportion of adult cases.

Where Eczema Appears: Distribution by Age

The distribution of eczema across the body changes significantly with age, reflecting shifts in skin maturity, immune development, and behavioral patterns such as scratching.

Infants (0 to 2 years)

In infants, eczema most commonly appears on the cheeks, forehead, and scalp first. The extensor surfaces of the limbs, including the shins and outer forearms, are also frequently affected. The nappy area is typically spared because the occluded, moisturized environment protects against barrier breakdown. The pattern in this age group is widespread, and the skin often appears weeping and crusted rather than dry and thickened.

Young children (2 to 12 years)

As children grow, the distribution shifts toward the flexural areas: the creases of the elbows and knees, the wrists, the ankles, and behind the ears. This flexural pattern is the most recognizable presentation of childhood atopic dermatitis and is the distribution most illustrated in standard dermatology textbooks. The face becomes less affected as the flexural pattern becomes dominant, though periorbital and perioral involvement continues in some children.

Adolescents and adults

In adults, eczema continues to affect the flexural areas but increasingly involves the hands, face, neck, upper chest, and scalp. Occupational factors play a greater role in adult distribution: frequent handwashing, contact with occupational irritants, and prolonged glove wearing are among the most common drivers of hand eczema in adults. Facial and eyelid involvement is proportionally more common in adults than in children. Lichenification, the thickening and hardening of skin from chronic scratching, is far more prominent in adult disease than in childhood eczema, producing a distinct leathery texture with exaggerated skin markings.

The Appearance of Eczema: How It Differs by Age

Beyond distribution, the visual appearance of eczema lesions changes with age.

In infants and young children, eczema tends to appear acutely inflamed: red, weeping, crusted, and oedematous. The skin reacts rapidly to triggers and can escalate quickly from mild redness to significant weeping within hours. Secondary infection with Staphylococcus aureus is common in infants and frequently presents as sudden worsening with honey colored crusting.

In adults, eczema more often presents as chronic rather than acute inflammation. The skin appears dry, thickened, and scaly. Lichenification is a hallmark of adult disease. Active weeping and crusting occur during flares but the dominant presentation between flares is dry, sensitized, barrier compromised skin rather than the acute redness more typical of infant eczema. Research published in the Journal of Investigative Dermatology confirmed that adult atopic dermatitis skin shows a more mixed Th2/Th1 cytokine profile compared to childhood disease, which is predominantly Th2-driven. This shift partly explains why adult eczema tends to look different and behaves more chronically.

Adult-Onset Eczema: A Distinct Presentation

Adult-onset eczema, developing for the first time after the age of 18, is a clinically distinct entity from childhood eczema that persists into adulthood. It accounts for approximately 1 in 4 adult eczema cases, according to a review published in the Journal of the European Academy of Dermatology and Venereology.

Adults developing eczema for the first time are less likely to have the classic filaggrin gene mutation that characterizes early-onset childhood atopic dermatitis. They are also less likely to have other atopic conditions including asthma and hay fever, suggesting a different underlying immunological driver. Occupational exposure, hormonal change, psychological stress, and new environmental allergen sensitization are among the most frequently identified precipitants of adult-onset disease.

The distinction matters clinically because adult-onset eczema is more likely to be misdiagnosed initially, either as contact dermatitis, psoriasis, or seborrhoeic dermatitis, and may require patch testing to exclude a contact allergen before a diagnosis of endogenous atopic dermatitis is confirmed.

Triggers: What Differs Between Adults and Children

Both adults and children share core eczema triggers including soaps, dust mites, fragranced products, and temperature extremes. However, several triggers are disproportionately relevant in adults.

Occupational irritants and allergens are a major driver of adult eczema that is largely irrelevant in childhood. Healthcare workers, hairdressers, catering staff, cleaners, and construction workers are among the highest-risk occupational groups. A review published in the British Journal of Dermatology found that occupational contact dermatitis accounts for up to 30% of eczema presentations in adults in these professions.

Hormonal fluctuations affect eczema in women across adulthood in ways not relevant in young children. Premenstrual worsening, pregnancy related changes, and perimenopausal eczema relapse are recognized patterns linked to oestrogen and progesterone fluctuations. Research published in the British Journal of Dermatology documented that 30 to 40% of women with atopic dermatitis report consistent premenstrual worsening.

Psychological stress operates through the same HPA axis and neuropeptide mechanisms in both adults and children, but the cumulative stress burden in adult life, including workplace pressure, financial stress, and relationship strain, tends to make stress a more frequently reported and more sustained trigger in adults than in children.

Food triggers are considerably less relevant in adults than in young children. Confirmed IgE-mediated food allergy as a driver of eczema is identified in fewer than 10% of adult cases, compared to up to 35% of children under five with moderate-to-severe disease, as established by NICE clinical guidance.

The Atopic March: From Childhood Eczema to Adult Allergic Disease

The atopic march describes the sequential development of allergic conditions over time, typically beginning with eczema in infancy, followed by food allergy, then allergic rhinitis, and then asthma as the child develops. It reflects the systemic immune dysregulation underlying atopic disease rather than eczema being confined to the skin.

A large prospective cohort study published in the Journal of Allergy and Clinical Immunology found that early onset, persistent eczema was a significant predictor of later asthma and hay fever, with the risk increasing in proportion to eczema severity in early childhood. Children with moderate to severe eczema persisting beyond age two had a 3-fold higher risk of developing asthma compared to children whose eczema cleared in infancy.

The atopic march continues to be relevant in adults: adults with a history of childhood eczema carry a higher lifetime risk of allergic rhinitis, asthma, and food allergy than the general population, and these conditions can themselves worsen or re-trigger eczema in adult life.

Prognosis: Does Childhood Eczema Go Away?

Approximately 60% of children with atopic dermatitis see significant improvement or apparent resolution of symptoms by their mid-twenties, according to research published in the British Journal of Dermatology following a cohort from childhood to adulthood. However, the same research found that a significant proportion of these individuals retained subclinical skin barrier abnormalities and remained susceptible to eczema relapse under the right conditions.

Around 40% of children with eczema will continue to have active symptoms into adulthood, with persistent disease most likely in those with early onset, greater severity, co-existing asthma, and confirmed filaggrin gene mutations.

Adult eczema is generally more persistent than childhood eczema. The likelihood of spontaneous remission decreases with age. Research published in the Journal of the American Academy of Dermatology found that adults with established atopic dermatitis had lower rates of remission over a 10-year period compared to pediatric cohorts, and that disease burden, including sleep disruption, psychological impact, and quality of life impairment, was significantly higher in adults than in children with equivalent clinical severity scores.

Treatment Differences Between Adults and Children

The core treatment principles are shared: emollients as the foundation, topical corticosteroids for flares, trigger identification and avoidance, and escalation to systemic therapy for inadequately controlled disease. However, the specific treatment landscape differs between age groups in several important ways.

Topical corticosteroid potency is guided more carefully in children due to the higher surface area to body weight ratio and thinner skin, which increases systemic absorption risk. Mild to moderate potency corticosteroids are the standard first line choice in children. Adults are more likely to require moderate to potent formulations for lichenified or chronic plaques.

Dupilumab is licensed for moderate-to-severe atopic dermatitis in adults, adolescents aged 12 and over, and children aged 6 and over in most regulatory jurisdictions, including approval from the FDA and EMA. The clinical trial data in paediatric populations, published across NEJM and JAMA Dermatology, confirmed efficacy and a similar safety profile to adults, though dosing is weight adjusted in younger patients.

JAK inhibitors including baricitinib and upadacitinib are currently licensed for adults and adolescents in most markets. Their use in younger children remains under evaluation in ongoing clinical trials.

Wet wrap therapy is used more frequently in children than in adults, particularly for widespread acute flares requiring intensive barrier repair and topical corticosteroid delivery. It is less practical and less commonly prescribed in adult disease.

Psychological support is proportionally underutilized in adults with eczema despite evidence that the psychological burden of adult disease exceeds that in children with equivalent severity. A study published in the British Journal of Dermatology found that adults with atopic dermatitis had significantly higher rates of anxiety and depression compared to age matched controls, and that these comorbidities were underdiagnosed and undertreated in dermatology outpatient settings.

Conclusion

Eczema is not a single uniform condition that looks and behaves the same at every age. The distribution, appearance, triggers, prognosis, and treatment priorities all shift significantly between infancy, childhood, and adulthood. Understanding these differences allows for more accurate expectations, more targeted management, and better conversations with clinicians about what is driving the disease at each stage of life.

Disclaimer

This article is for informational purposes only and does not constitute medical advice. If you are concerned about eczema in yourself or your child, or if symptoms are not responding to over-the-counter treatment, consult a doctor dermatologist for an individualized assessment and management plan.

References

• NICE — Atopic eczema in under 12s: diagnosis and management (CG57): https://www.nice.org.uk/guidance/cg57

• NHS — Atopic eczema: https://www.nhs.uk/conditions/atopic-eczema/

• National Eczema Association — Eczema in children: https://nationaleczema.org/eczema/children/

• Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. The Lancet. 2020: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31286-1/fulltext

• Bieber T. Atopic dermatitis. New England Journal of Medicine. 2008: https://www.nejm.org/doi/full/10.1056/NEJMra074081

• Gittler JK et al. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. Journal of Allergy and Clinical Immunology. 2012: https://www.jacionline.org/article/S0091-6749(12)00821-5/fulltext

• Illi S et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. Journal of Allergy and Clinical Immunology. 2004: https://www.jacionline.org/article/S0091-6749(04)00497-5/fulltext

• Werfel T et al. Adult-onset atopic dermatitis: characteristics, diagnosis, and management. Journal of the European Academy of Dermatology and Venereology. 2021: https://onlinelibrary.wiley.com/doi/10.1111/jdv.16988

• Silverberg JI et al. Prevalence and persistence of atopic dermatitis in adults. Journal of the American Academy of Dermatology. 2020: https://www.jaad.org/article/S0190-9622(19)32981-5/fulltext

• Williams HC et al. Natural history of childhood atopic dermatitis. British Journal of Dermatology. 1998: https://academic.oup.com/bjd/article/139/5/834/6697853

• Ramirez FD et al. Premenstrual flare in women with atopic dermatitis. British Journal of Dermatology. 2019: https://academic.oup.com/bjd

• Dalgard FJ et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological outpatients in 13 European countries. Journal of Investigative Dermatology. 2015: https://www.jidonline.org/article/S0022-202X(15)36426-1/fulltext

• Thyssen JP, Hamann CR, Linneberg A et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalizations. British Journal of Dermatology. 2018: https://academic.oup.com/bjd/article/179/2/360/6691382

• Boguniewicz M et al. Dupilumab for adolescents with uncontrolled moderate-to-severe atopic dermatitis. JAMA Dermatology. 2020: https://jamanetwork.com/journals/jamadermatology/fullarticle/2762372

• Simpson EL et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. New England Journal of Medicine. 2016: https://www.nejm.org/doi/full/10.1056/NEJMoa1610020

• Cabanillas B, Brehler AC, Novak N. Atopic dermatitis phenotypes and the need for personalized medicine. Current Opinion in Allergy and Clinical Immunology. 2017: https://journals.lww.com/co-allergy/abstract/2017/06000/atopic_dermatitis_phenotypes_and_the_need_for.2.aspx

• British Association of Dermatologists — Atopic Eczema Patient Information Leaflet: https://www.bad.org.uk/pils/atopic-eczema/

Call To Action

This article is part of the PharmaHealths skin health series. My articles on why eczema keeps coming back, eczema triggers to avoid, skin barrier repair, and best moisturizers for eczema cover the foundations of management at any age. For adults with moderate-to-severe disease exploring biologic options, my guide to dupilumab (Dupixent) covers the treatment in depth. All available at pharmahealths.com

Q1. How is eczema different in adults compared to children?

In children, eczema typically appears acutely inflamed, weeping, and crusted, commonly on the cheeks in infants and the flexural creases of the elbows and knees in older children. In adults, eczema more often presents as chronic, dry, thickened, and lichenified skin, frequently affecting the hands, face, neck, and upper chest alongside the flexural areas. The underlying immune profile also shifts with age, producing a more mixed inflammatory pattern in adults compared to the predominantly Th2-driven pattern in children.

Q2. Does childhood eczema go away as children get older?

Approximately 60% of children with atopic dermatitis see significant improvement or apparent resolution by their mid-twenties. Around 40% will continue to have active symptoms into adulthood, with persistent disease most likely in those with early onset, severe childhood disease, co-existing asthma, and filaggrin gene mutations. Even in those whose symptoms appear to resolve, subclinical skin barrier abnormalities typically persist, leaving susceptibility to relapse under the right conditions.

Q3. Can you develop eczema for the first time as an adult?

Yes, Adult-onset eczema, developing for the first time after age 18, accounts for approximately 1 in 4 adult eczema cases. It is clinically distinct from childhood eczema persisting into adulthood: adult-onset disease is less likely to involve filaggrin mutations or co existing atopic conditions, and is more commonly linked to occupational exposure, hormonal change, or new environmental sensitisation.

Q4. Where does eczema appear on adult’s vs children?

In infants, eczema most commonly appears on the cheeks, forehead, and scalp, then shifts to the outer limbs. In older children, it moves to the flexural creases of the elbows, knees, wrists, and ankles. In adults, the flexural areas remain involved but eczema increasingly affects the hands, face, neck, upper chest, and scalp. Lichenification, the leathery skin thickening from chronic scratching, is far more prominent in adult distribution than in childhood disease.

Q5. Is adult eczema harder to treat than childhood eczema?

Adult eczema tends to be more chronic and less likely to resolve spontaneously than childhood eczema. The more mixed immune profile in adults, the greater role of occupational and hormonal triggers, and the higher psychological burden all contribute to a condition that is often mor difficult to fully control in adults. Access to biologics including dupilumab has significantly improved outcomes for moderate to severe adult disease.

Q6. What triggers eczema in adults that does not affect children?

Occupational irritants and allergens are a major adult specific trigger category, particularly in healthcare, hairdressing, catering, and construction. Hormonal fluctuations including premenstrual changes, pregnancy, and perimenopause are relevant in adult women but not in young children. Cumulative psychological stress from work and life pressures is a more sustained trigger in adults than in children.

Q7. Does eczema get worse with age?

Eczema does not inevitably worsen with age, but in adults whose disease has not resolved from childhood, symptoms tend to become more chronic and persistent over time. New triggers including occupational exposure and hormonal change can worsen or reactivate previously stable eczema in adulthood. With appropriate treatment including emollients, trigger avoidance, and biologics where indicated, most adults achieve meaningful disease control.

Q8. What is the atopic march and does it affect adults?

The atopic march describes the sequential development of allergic conditions, typically starting with eczema in infancy, followed by food allergy, allergic rhinitis, and asthma. It affects adults in that a history of childhood eczema carries a higher lifetime risk of these conditions, which can themselves worsen or re-trigger eczema in adult life. Adults with a childhood eczema history are 3 times more likely to develop asthma compared to those without early eczema, based on prospective cohort data published in the Journal of Allergy and Clinical Immunology.

Q9. Is eczema treatment the same for adults and children?

The core approach is shared: emollients as the daily foundation, topical corticosteroids for flares, and escalation for inadequately controlled disease. Key differences include more cautious corticosteroid potency selection in children due to absorption risk, dupilumab being licensed from age 6 in most markets, JAK inhibitors currently more restricted in younger children, and wet wrap therapy being used more frequently in paediatric practice. Psychological support.

Q10. Why is adult eczema often more persistent than childhood eczema?

Adult eczema is driven by a more complex, mixed immune profile than childhood disease, involves a broader range of triggers including occupational and hormonal factors, and lacks the immune maturation process that allows many children to improve over time. The subclinical skin barrier dysfunction that persists even in apparent remission means the adult skin remains structurally vulnerable to relapse, and without the developmental changes of childhood that sometimes resolve the condition naturally, adult eczema tends to require sustained long-term management.